Our present study demonstrated that serum RBP4, a well-known adipokine with adverse effects on cardiovascular system, was not only correlated with thyroid dysfunction, but also strongly associated with CAD in patients with SCH. This evidence concerns the gene RBP4 and coronary artery disorder.